Improving healthcare professionals' interactions with patients to tackle antimicrobial resistance: a systematic review of interventions, barriers, and facilitators.


Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2024
Historique:
received: 03 01 2024
accepted: 30 04 2024
medline: 6 6 2024
pubmed: 6 6 2024
entrez: 6 6 2024
Statut: epublish

Résumé

Antimicrobial resistance (AMR) is a major public health threat. With the growing emphasis on patient-centred care/ shared decision making, it is important for healthcare professionals' (HCPs) who prescribe, dispense, administer and/or monitor antimicrobials to be adequately equipped to facilitate appropriate antimicrobial use. We systematically identified existing interventions which aim to improve HCPs interaction with patients and examined barriers and facilitators of appropriate the use of such interventions and appropriate antimicrobial use among both HCPs and patientsantimicrobial use while using these interventions. We searched MEDLINE, EMBASE, Web of Science, Google Scholar, and internet (via Google search engine). We included primary studies, published in English from 2010 to 2023 [PROSPERO (CRD42023395642)]. The protocol was preregistered with PROSPERO (CRD42023395642). We performed quality assessment using mixed methods appraisal tool. We applied narrative synthesis and used the COM-B (Capability, Opportunity, Motivation -Behaviour) as a theoretical framework for barriers and facilitators at HCP and patient levels. Of 9,172 citations retrieved from database searches, From 4,979 citations remained after removal of duplicates. We included 59 studies spanning over 13 countries. Interventions often involved multiple components beyond HCPs' interaction with patients. From 24 studies reporting barriers and facilitators, we identified issues relating to capability (such as, knowledge/understanding about AMR, diagnostic uncertainties, awareness of interventions and forgetfulness); opportunity (such as, time constraint and intervention accessibility) and motivation (such as, patient's desire for antibiotics and fear of litigation). The findings of this review should be considered by intervention designers/adopters and policy makers to improve utilisation and effectiveness.

Identifiants

pubmed: 38841670
doi: 10.3389/fpubh.2024.1359790
pmc: PMC11150712
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1359790

Informations de copyright

Copyright © 2024 Ayorinde, Ghosh, Shaikh, Adetunji, Brown, Jordan, Gilham, Todkill and Ashiru-Oredope.

Déclaration de conflit d'intérêts

DA-O, DT, and EG were employed by the funder of the study, UK Health Security Agency (UKHSA). The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Abimbola Ayorinde (A)

Warwick Medical School, University of Warwick, Coventry, United Kingdom.

Iman Ghosh (I)

Warwick Medical School, University of Warwick, Coventry, United Kingdom.

Junaid Shaikh (J)

Warwick Medical School, University of Warwick, Coventry, United Kingdom.

Victoria Adetunji (V)

Warwick Medical School, University of Warwick, Coventry, United Kingdom.

Anna Brown (A)

Warwick Medical School, University of Warwick, Coventry, United Kingdom.

Mary Jordan (M)

Warwick Medical School, University of Warwick, Coventry, United Kingdom.

Ellie Gilham (E)

Warwick Medical School, University of Warwick, Coventry, United Kingdom.

Daniel Todkill (D)

Warwick Medical School, University of Warwick, Coventry, United Kingdom.

Diane Ashiru-Oredope (D)

UK Health Security Agency, London, United Kingdom.
School of Pharmacy, University of Nottingham, Nottingham, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH